Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology

H. W. Hui, J. R. Robinson and V. H. L. Lee, Design and Fabrication of Oral Controlled Release Drug Delivery Systems, in Controlled Drug Delivery: Fundamentals and Applications (Eds. J. R. Robinson and V. H. L. Lee), 2^nd ed., Marcel Dekker, New York 1987, pp. 373-374.10.1201/b14193-12Search in Google Scholar

R. K. Verma, B. Mishra and S. Garg, Osmotically controlled oral drug delivery, Drug Dev. Ind. Pharm. 26 (2000) 695-708; DOI: 10.1081/DDC-100101287.10.1081/DDC-100101287Search in Google Scholar

M. Speers and C. Bonnano, Economic Aspects of Controlled Drug Delivery, in Encyclopedia of Controlled Drug Delivery (Ed. E. Mathiowitz), Wiley, New York 1999, pp. 341-347.Search in Google Scholar

R. K. Verma, D. M. Krishna and S. Garg, Formulation aspects in the development of osmotically controlled oral drug delivery systems, J. Control. Rel. 79 (2002) 7-27; DOI: 10.1016/j.conrel.2003.09.009.Search in Google Scholar

F. Theeuwes, Elementary osmotic pump, J. Pharm. Sci. 64 (1975) 1987-1991; DOI: 10.1002/jps. 2600641218.Search in Google Scholar

P. Kumar, S. Singh, P. S. Rajinikanth and B. Mishra, An overview of osmotic pressure controlled release formulation, J. Pharm. Res. 5 (2006) 34-45.Search in Google Scholar

P. Kumar and B. Mishra, An overview of recent patents on oral osmotic drug delivery systems, Recent Patents on Drug. Del. Form. 1 (2007) 236-255; DOI: 10.2174/187221107782331638.10.2174/187221107782331638Search in Google Scholar

S. A. Schug, Tramadol in acute pain, Acute Pain 5 (2003) 1-3; DOI: 10.1016/S1366-0071(03) 00028-7.Search in Google Scholar

C. Mattia and F. Coluzzi, Once-daily tramadol in rheumatological pain, Expert. Opin. Pharmacother. 7 (2006) 1811-1815; DOI: 10.1517/14656566.7.13.1811.10.1517/14656566.7.13.1811Search in Google Scholar

S. B. Tiwari, K. Murthy, M. R. Pai, P. R. Mehta and P. S. Choudhary, Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system, AAPPS Pharm. Sci. Tech. 4 (2003) 1-6.Search in Google Scholar

P. Kumar, S. Singh and B. Mishra, Gastroretentive drug delivery system of ranitidine hydrochloride based on osmotic technology: development and evaluation, Curr. Drug Del. 5 (2008) 332-342; DOI: 10.2174/156720108785914943.10.2174/156720108785914943Search in Google Scholar

J. Shokri, P. Ahmedi, P. Rashidi, M. Shahsavri, A. R. Siahboomi and A. Nokhodchi, Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water soluble drugs, Eur. J. Pharm. Biopharm. 68 (2008) 289-297; DOI: 10.1016/j.ejpb.200706.006.Search in Google Scholar

United States Pharmacopoeia 30, National Formulary vol. 1, USP Convention, Rockville 2007.Search in Google Scholar

C. Aguzzi, M. C. Bonferoni, M. R. Osorio, F. S. Rossi, F. Ferrari and C. Caramella, Influence of complex solubility on formulations based on lambda carrageenan and basic drugs, AAPPS Pharm. Sci. Tech. 3 (2002) 1-7.Search in Google Scholar

M. R. Rouini, Y. H. Ardakani, F. Soltani, H. Y. Aboul-Enein and A. Foroumadi, Development and validation of rapid HPLC method for simultaneous determination of tramadol and its metabolites in human plasma, J. Chromatogr. B. 830 (2006) 207-211; DOI: 10.1016/j.jchromb.2005.10.039.10.1016/j.jchromb.2005.10.039Search in Google Scholar

A. Kucuk, Y. Kadioglu and F. Celebi, Investigation of the pharmacokinetics and determination of tramadol in rabbit plasma by a high-performance liquid chromatography-diode array detector method using liquid-liquid extraction, J. Chrom. B. 816 (2005) 203-208; DOI: 10.1016/j.jchromb. 2004.11.031.Search in Google Scholar

P. Costa and J. M. S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1Search in Google Scholar

B. Mishra, B. V. Bakde, P. N. Singh and P. Kumar, Development and in-vitro evaluation of oral sustained release formulation of tramadol hydrochloride, Acta Pharm. Sci. 48 (2006) 153-166.Search in Google Scholar

X. Li, W. Pan, S. Nie and L. Wu, Studies on controlled release effervescent osmotic pump tablets from traditional Chinese medicine compound recipe, J. Control. Rel. 96 (2004) 359-367; DOI: 10.1016/j/jconrel.2004.01.026.Search in Google Scholar

N. Sinchaipanid, S. Pongwai, P. Limsuwan and A. Mitrevej, Design of salbutamol EOP tablets from pharmacokinetic parameters, Pharm. Dev. Technol. 8 (2003) 135-142; DOI: 10.1081/PDT-120018479.10.1081/PDT-120018479Search in Google Scholar

F. Musshoff and B. Madea, Fatality due to ingestion of tramadol alone, Forensic Sci. Int. 116 (2001) 197-199; DOI: 10.1016/s0379-0738(00)00374-1.10.1016/S0379-0738(00)00374-1Search in Google Scholar

A. M. Razaghi and J. B. Schwartz, Investigation of cyclobenzaprine hydrochloride release from oral osmotic delivery systems containing a water swellable polymer, Drug Dev. Ind. Pharm. 28 (2002) 631-639; DOI: 10.1018.DDC-120003855.10.1081/DDC-120003854Search in Google Scholar

A. M. Razaghi and J. B. Schwartz, Release of cyclobenzaprine hydrochloride from osmotically rupturable tablets, Drug. Dev. Ind. Pharm. 28 (2002) 695-701; DOI: 10.1081/DDC-120003861.10.1081/DDC-120003861Search in Google Scholar

ICH Q1A (R2), Stability Testing Guidelines: Stability Testing of New Drug Substances and Products, EMEA, London 2003.Search in Google Scholar